ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.216,19
1,54%
S&P 500
5.975,38
0,55%
Dow Jones
42.706,56
-0,06%
Euro vs US Dollar
1,03805
-0,03%
Bitcoin
101.894,63
-0,38%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE

  6. Bivictrix Therapeutics Plc (BVX) Börsenkurse

Bivictrix Therapeutics Plc

Bivictrix Therapeutics Plc (BVX)

LSE
10,00
0,00
(0,00%)
Geschlossen 07 Januar 5:30PM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
10,00
Gebot
8,50
Fragen
9,50
Volumen
0,00
0,00 Tagesbereich 0,00
7,50 52-Wochen-Bereich 13,00
Marktkapitalisierung
8,253M
Handelsende
10,00
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
0,00
Ausgegebene Aktien
82.526.088
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,25
Gewinn pro Aktie (EPS)
-0,03
Erlöse
-
Nettogewinn
-2,55M

Über Bivictrix Therapeutics Plc

Sektor
Coml Physical, Biologcl Resh
Branche
Coml Physical, Biologcl Resh
Website
www.bivictrix.com
Hauptsitz
Manchester, Gbr
Gegründet
-
Bivictrix Therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the Londoner Börse with ticker BVX. The last closing price for Bivictrix Therapeutics was 10,00p. Over the last year, Bivictrix Therapeutics shares have traded in a share price range of 7,50p to 13,00p.

Bivictrix Therapeutics currently has 82.526.088 shares in issue. The market capitalisation of Bivictrix Therapeutics is £8,25 million. Bivictrix Therapeutics has a price to earnings ratio (PE ratio) of -3.25.

BVX Neueste Nachrichten

Weitere Nachrichten

AIM Cancellation - BiVictriX Therapeutics plc

AIM 11 September 2024   NOTICE   11/09/2024 - 07:00   NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM   At the request of the Company the following securities have been cancelled from...

11 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 10 September 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

10 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Last Day of Dealings

BiVictriX Therapeutics PLC 10 September 2024   BiVictriX Therapeutics plc   ("BiVictriX", "BiVictriX Therapeutics" or the "Company")   Last Day of Dealings   Alderley Park, 10 September 2024...

10 September 2024
RNS Regulatory News

Bivictrix Therapeutics optimistic about BVX002 after in vivo testing

Bivictrix Therapeutics PLC announced on Monday it has received "positive" in vivo test results from its BVX002 solid ...

09 September 2024
Alliance News

BiVictriX Therapeutics PLC Positive In Vivo Data from BVX002 Programme

BiVictriX Therapeutics PLC 09 September 2024   This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by...

09 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 02 September 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

02 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Director Dealing

BiVictriX Therapeutics PLC 02 September 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF...

02 September 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Result of General Meeting

BiVictriX Therapeutics PLC 29 August 2024   This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by...

29 August 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 28 August 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

28 August 2024
RNS Regulatory News

BiVictriX Therapeutics PLC Holding(s) in Company

BiVictriX Therapeutics PLC 28 August 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BNXH3K91 Issuer Name BIVICTRIX THERAPEUTICS PLC UK or Non-UK...

28 August 2024
RNS Regulatory News
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10010101000DE
40010101000DE
120010101000DE
26-3-23.076923076913137.5856138.54160452DE
52-1-9.0909090909111137.5475318.8175654DE
156-19.5-66.101694915329.533.57.54506916.76812367DE
260-12.5-55.555555555622.533.57.55825318.38626009DE

BVX - Frequently Asked Questions (FAQ)

What is the current Bivictrix Therapeutics share price?
The current share price of Bivictrix Therapeutics is 10,00p
How many Bivictrix Therapeutics shares are in issue?
Bivictrix Therapeutics has 82.526.088 shares in issue
What is the market cap of Bivictrix Therapeutics?
The market capitalisation of Bivictrix Therapeutics is GBP 8,25M
What is the 1 year trading range for Bivictrix Therapeutics share price?
Bivictrix Therapeutics has traded in the range of 7,50p to 13,00p during the past year
What is the PE ratio of Bivictrix Therapeutics?
The price to earnings ratio of Bivictrix Therapeutics is -3,25
What is the reporting currency for Bivictrix Therapeutics?
Bivictrix Therapeutics reports financial results in GBP
What is the latest annual profit for Bivictrix Therapeutics?
The latest annual profit of Bivictrix Therapeutics is GBP -2,55M
What is the registered address of Bivictrix Therapeutics?
The registered address for Bivictrix Therapeutics is C/O SLATER HEELIS LIMITED, 86 DEANSGATE, MANCHESTER, M3 2ER
What is the Bivictrix Therapeutics website address?
The website address for Bivictrix Therapeutics is www.bivictrix.com
Which industry sector does Bivictrix Therapeutics operate in?
Bivictrix Therapeutics operates in the COML PHYSICAL, BIOLOGCL RESH sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SCGLSealand Capital Galaxy Limited
3,25p
(103,13%)
12,18M
BORBorders & Southern Petroleum Plc
3,64p
(51,04%)
23,81M
NEONeo Energy Metals Plc
0,95p
(22,58%)
37,84M
GNIPGenip Plc
32,00p
(20,75%)
192,82k
ZIOCZanaga Iron Ore Company Limited
10,50p
(19,86%)
2,84M
DGIDg Innovate Plc
0,02p
(-20,00%)
298,54M
SNGSynairgen Plc
2,10p
(-19,39%)
1,67M
VRSVersarien Plc
0,03p
(-18,92%)
103,72M
QEDQuadrise Plc
5,90p
(-17,83%)
17,66M
ZENZenith Energy Ltd.
4,90p
(-16,24%)
1,48M
SYMESupply@me Capital Plc
0,0042p
(12,00%)
1,19B
MSMNMosman Oil And Gas Limited
0,035p
(12,90%)
654,48M
TRPTower Resources Plc
0,0395p
(0,00%)
570,56M
CPXCap-xx Limited
0,1775p
(-2,74%)
379,2M
NTVONativo Resources Plc
0,0019p
(-5,00%)
312,89M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

LSE
BVX
Bivictrix Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten